Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., et al., No. 1:2019cv01979 - Document 646 (D. Del. 2023)

Court Description: TRIAL OPINION (Regarding the '569 Patent): For the foregoing reasons, I find the asserted claims of the '659 Patent invalid for lack of written description. The parties shall submit a final judgment consistent with this memorandum opinion within one week (see Opinion for further details). Signed by Judge Richard G. Andrews on 7/7/2023. Associated Cases: 1:20-md-02930-RGA, 1:19-cv-01979-RGA, 1:19-cv-02021-RGA, 1:19-cv-02053-RGA(nms)